Research progress on the different treatment options for stage ⅡB cervical cancer
10.3760/cma.j.issn.1008-1372.2019.06.042
- VernacularTitle:ⅡB期宫颈癌不同治疗方案的研究进展
- Author:
Di ZHANG
1
;
Pan ZHANG
;
Xiaobo DAI
Author Information
1. 重庆医科大学附属第一医院肿瘤科 400016
- Keywords:
Uterine cervical neoplasms;
Chemoradiotherapy;
Chemotherapy,adjuvant;
Trachelectomy;
Review
- From:
Journal of Chinese Physician
2019;21(6):951-954
- CountryChina
- Language:Chinese
-
Abstract:
Cervical cancer is an important global public health problem,and its incidence tends to be younger in China.Compared with stage ⅡB cervical cancer,concurrent chemoradiotherapy has obvious advantages in reducing local recurrence rate,improving progression free survival rate,overall survival rate,and improving prognosis.Concurrent chemoradiotherapy and surgical treatment can effectively reduce local lesions and increase the opportunity for surgical resection.Synchronous radiotherapy and chemotherapy do not increase the difficulty of operation and postoperative complications.At the same time,all kinds of short-term and long-term complications caused by radical radiotherapy are avoided.The new adjuvant chemotherapy will strive for radical surgery,using radical surgery to eliminate the focus of radiotherapy and chemotherapy,improve the patient's survival time and improve the patient's quality of life.Preoperative radiotherapy can also maintain the physiological function of the vagina and avoid various complications caused by the amount of radical radiotherapy.
